Mechanistic Thyroid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
VIRGINIA BEACH, Va., March 12, 2021 /PRNewswire/  LifeNet Health LifeSciences will showcase its portfolio of innovative human cell- and tissue-based research solutions including the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes at the Society of Toxicology (SOT) virtual annual meeting and ToxExpo at booth #1322. LifeSciences provides researchers human-relevant research solutions to optimize outcomes and speed the drug discovery process.
Our unique innovations are designed to accelerate drug discovery, validation, and safety testing by bringing new levels of precision and consistency to
in vitro biology, said Louis Dias, Vice President and General Manager of LifeNet Health LifeSciences. The combination of our processes and unrivaled capabilities means we can offer scientists the right cells, models, and biospecimens to deliver breakthrough results. ....

Rony Thomas , Ed Lecluyse , Louis Dias , Neda Rogers , Society Of Toxicology , Lifenet Health Lifesciences , Lifenet Health Lifescience , Lifenet Health , Vice President , General Manager , Net Health Lifesciences , Scientist Ed Lecluyse , Silico New Approach Methodologies , Mechanistic Thyroid , Primary Human Thyrocytes , Thyroid Disruptive , Lifenet Health President , றோணி தாமஸ் , லூயிஸ் டயஸ் , எடா ரோஜர்ஸ் , சமூகம் ஆஃப் நச்சுயியல் , ஆயுட்காலம் ஆரோக்கியம் ஆயுள் அறிவியல் , ஆயுட்காலம் ஆரோக்கியம் , துணை ப்ரெஸிடெஂட் , ஜநரல் மேலாளர் , நிகர ஆரோக்கியம் ஆயுள் அறிவியல் ,